Navtemadlin and Radiation Therapy in Treating Patients With Soft Tissue Sarcoma

NCT03217266 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

39

Enrollment

NIH

Sponsor class

Conditions

Resectable Soft Tissue Sarcoma
Soft Tissue Sarcoma

Interventions

DRUG: Navtemadlin
RADIATION: Radiation Therapy
PROCEDURE: Surgical Procedure

Sponsor

National Cancer Institute (NCI)

Collaborators

[object Object]